MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease.

about

MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease.

Item

http://www.wikidata.org/entity/Q55233718

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease.

@en

MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease.

@nl

type

Item

label

MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease.

@en

MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease.

@nl

prefLabel

MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease.

@en

MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease.

@nl

P1476

MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease.

@en

P2093

Beata Jolda-Mydlowska

http://www.w3.org/2001/XMLSchema#string

Justyna Krzysztofik

http://www.w3.org/2001/XMLSchema#string

Malgorzata Kobusiak-Prokopowicz

http://www.w3.org/2001/XMLSchema#string

P2860

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Novel indicators of fibrosis-related complications in children with chronic kidney disease.

Membrane-associated matrix proteolysis and heart failure.

Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?

Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors.

Myocardial remodelling and matrix metalloproteinases in heart failure: turmoil within the interstitium.

Matrix metalloproteinases: regulation and dysregulation in the failing heart.

Markers of increased cardiovascular risk in patients with chronic kidney disease.

Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9

P304

237-246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/MED-2018-0037

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrzej Mysiak

Konrad Kaaz

P577

2018-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29915813

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

P932

6004519

http://www.w3.org/2001/XMLSchema#string